MEDP - Total Utang marang Modal Medpace Corp

Logo perusahaan publik Medpace Holdings, Inc. (MEDP)

Medpace Holdings, Inc. (MEDP) provides global logistics for biosamples with strict temperature control, maintaining a powerful defensive moat due to the complexity of switching partners under FDA standards. The d/e ratio (total debt to equity) helps identify overleverage risks in a timely manner, with the metric currently standing at 0.28. Business scaling relies on digital platforms that enable the efficient management of numerous clinical trials.

MEDP: Total Utang marang Modal Medpace 04.07.2022 - 31.10.2026

Rincian analitis perusahaan Medpace Holdings, Inc.

- rega lan prakiraan konsensus rega:
Bagan rega Medpace|MEDP - Bagan tingkat prakiraan
- statistik kapitalisasi pasar:
Kapitalisasi pasar Medpace|MEDP - Nilai Dipunlarasaken Utang lan Kas
- indikator kapitalisasi buku:
Nilai Buku saben Saham Medpace|MEDP - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku medpace.com|MEDP - Nilai Agregat Aset
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas Medpace Holdings, Inc.|MEDP - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Medpace Holdings, Inc.|MEDP - Gunggung utang perusahaan|Utang marang nilai buku Medpace|MEDP - Silihan lan utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Medpace|Rasio cepet medpace.com
- informasi bathi lan kelipatan valuasi:
MEDP - Penghasilan resik perusahaan
Analisis dhasar perusahaan:Medpace
Barang utama Medpace Corp

Investors determine the financial stability of Medpace Holdings, Inc. (MEDP) through an analysis of its debt load. The clinical research outsourcing model utilizing external laboratories minimizes the need for capital expenditures. This debt-to-equity ratio compares the total amount of liabilities against the company's own equity. A low ratio confirms the business's independence from creditors. Such a profile characterizes the asset as conservative and defensive.

Analisis pesaing Medpace Holdings, Inc.

Utang marang Ekuitas IQVIA|Labcorp Holdings - Utang Agregat marang Ekuitas|Total Utang marang Modal ICLR|CRL (Charles River Corp) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal EVO (Evotec SE)|Total Utang marang Modal fortrea.com FTRE|LFCR - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi OABI (OmniAb Inc.)|Inotiv Corp (NOTV) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Avid Bioservices Inc|CTLT (Catalent, Inc.) - Total Utang marang Modal|Total Utang marang Modal nighthawkbio.com